Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-30

Clinical Trial Update: Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ketorolac as an option for post-operative pain management after elective cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Coronary Artery Disease, Post Operative Pain | Phase 4 | Status: COMPLETED